We have cloned many genes of β1,3-glycosyltransferases, which transfer sugars via a β1,3-linkage, and have characterized their biological functions. Among β1,3-glycosyltransferases, β1,3-N-acetylglucosaminyltransferases (β3GnTs) synthesize a unique carbohydrate structure known as "polylactosamine (poly-N-acetyllactosamine)". Polylactosamine is carried on N-and O-glycans, and on glycolipids. Polylactosamine structures are considered to be integral components serving as a fundamental structure and backbone for carbohydrate structures. However, most of their biological functions are still unknown. To investigate the in vivo function of polylactosamine on glycoconjugates, we generated and analyzed two mouse lines of β1,3-Nacetylglucosaminyltransferase (B3gnt)-deficient (B3gnt2 -/-or B3gnt5 -/-) mice lacking the polylactosamine structure. F i r s t , t o i n v e s t i g a t e t h e i n v i v o f u n c t i o n o f polylactosamine on glycoproteins, we analyzed gene knockout mice lacking B3gnt2, which synthesizes polylactosamine on glycoproteins. In B3gnt2 -/-mice, glycan analysis demonstrated that the amount of long polylactosamine chains on N-glycan was greatly reduced in the tissues of B3gnt2 -/-mice. We also examined immunological responses in B3gnt2 -/-mice. B3gnt2
) mice lacking the polylactosamine structure. F i r s t , t o i n v e s t i g a t e t h e i n v i v o f u n c t i o n o f polylactosamine on glycoproteins, we analyzed gene knockout mice lacking B3gnt2, which synthesizes polylactosamine on glycoproteins. In B3gnt2 -/-mice, glycan analysis demonstrated that the amount of long polylactosamine chains on N-glycan was greatly reduced in the tissues of B3gnt2 -/-mice. We also examined immunological responses in B3gnt2 -/-mice. B3gnt2
-/-lymphocytes showed hyperactivation via TCR/CD28 or BCR stimulation.
N e x t , t o i n v e s t i g a t e t h e i n v i v o f u n c t i o n o f polylactosamine on glycosphingolipids (glycolipid), we analyzed B3gnt5
-/-mice lacking lacto/neolacto-series glycolipids. B3gnt5 -/-B cells showed an abnormality of glycolipid-enriched microdomains (GEMs; also known as glycolipid rafts) and showed hyperactivation via BCR-related molecules in GEMs, as compared with wild-type (WT) B cells.
Polylactosamine deficiency seems to be involved in the immunological disorders observed in these mice. Taken together, these studies suggest that the polylactosamine chain is a putative immune regulatory factor that presumably suppresses excessive responses during immune reactions and has an important biological role in the immune system.
A . Introduction P o l y l a c t o s a m i n e -c o n t a i n i n g r e p e a t s o f t h e N-acetyllactosamine (LacNAc) unit (Gal[galactose] β1-4GlcNAc[N-acetylglucosamine] β1-3)n represent a fundamental structure of glycans carried on N-, and O-glycans, as well as on glycosphingolipids (glycolipids) (1) (2) (3) (Fig. 1A) . Polylactosamine is coordinately synthesized by the alternative action of a β1,4-galactosyltransferase (β4GalT) and a β1,3-N-acetylglucosaminyltransferase (β3GnT) (4) . It is considered that polylactosamine chains form an important scaffold that serves as a backbone for the carbohydrate structures.
The human blood group i antigen structure and I antigen structure have been characterized as linear and β1-6-branching polylactosamine structures, respectively (5, 6) . It is also known that polylactosamine functions as a ligand for some endogenous lectins such as galectins (7) . This indicates that the polylactosamine structure is a biofunctional carbohydrate structure. Furthermore, polylactosamine chains are further modified by the addition of different carbohydrate antigens such as Lewis blood group antigens, including Lewis x (Le x , CD15, SSEA-1) antigen, HNK-1 (CD57) antigen, and keratan sulfate, which is a glycosaminoglycan containing sulfated polylactosamine. Therefore, it seems that polylactosamine plays many roles in biological processes by bearing various functional carbohydrate antigens on its structure.
For example, it is well known that sialyl Lewis x (sLe x , CD15s) antigens exist on the non-reducing end of polylactosamine structures. sLe x structure functions as a ligand for adhesion molecules such as selectin on lymphocyte homing. sLe x antigen is an important structure for lymphocyte accumulation and infiltration to inflammation sites (8) (9) (10) (11) . This suggested that the polylactosamine structure might be related to lymphocyte homing. In addition, the length of the polylactosamine chain is also an important factor in immune responses. Polylactosamine inhibits NK cell-mediated cytotoxicity during binding to the target cell (12) . On the other hand, it is considered that sLe x on polylactosamine and the length of the polylactosamine chain is related to malignancy (cancer metastasis). In cancer metastasis, both highly and poorly metastatic tumor cells derived from the same patient were found to express almost the same amount of sLe x antigens, regardless of different metastatic ability. However, sLe x in N-glycans with a shorter polylactosamine chain is more abundant in poorly metastatic colon carcinoma cells (13) . These results suggested that both polylactosamine structure and length might also be important in tumor malignancy and cell-cell interactions. Thus, it is thought that the polylactosamine structure has various biological functions, either direct or indirect.
A t p r e s e n t , m a n y b i o l o g i c a l f u n c t i o n s o f polylactosamine have been identified in vitro, but little is known of their functions in vivo and their molecular mechanisms.
B. Cloning of a Set of β1,3-N-Acetylglucosaminyltransferases

Involved in Synthesis of Polylactosamine Chains
The first cloned glycosyltransferase gene, β1,4-galactosyltransferase I (β4GalT1), was cloned and characterized by Narimatsu et al. in 1986 (14) . Thereafter, many glycosyltransferase genes have been cloned by enzyme purification, expression cloning, searching for homologous genes by Southern Blot analysis, and PCR cloning with degenerate primers. In addition, the biological functions of glycosyltransferases have been characterized. As a consequence of recent improvements in database construction and bioinformatics technology, in silico cloning of glycosyltransferase genes has become the mainstream technique. Currently, over 186 kinds of glycosyltransferase gene have been isolated and characterized by many laboratories. As a result, it has been found that the glycosyltransferase genes form several subfamilies, and that the amino acid sequences in these subfamilies contain wellconserved motifs. It is known that glycosyltransferases have some specificity. The properties conserved in each subfamily reflect their enzymatic character as follows: (1) donor specificity, (2) acceptor specificity (sequence of carbohydrate chains), and (3) anomer specificity (specificity for anomeric bond; i.e., the specific linkage between donor and acceptor).
As described above, gene cloning by database (in silico) searching has become mainstream in recent years. Our group and many others have been pursuing the cloning of a novel set of glycosyltransferase genes belonging to the β3-glycosyltransferase family by searching for a unique sequence specific to β3-glycosyltransferase (especially the β3GT motif, Fig. 1B ) (15) (16) (17) (18) (19) (20) (21) .
At present, the β1,3-galactosyltransferase (β3GalT), β1,3-N-acetylgalactosaminyltransferase (β3GalNAcT), and β3GnT groups that have been isolated and reported to date are known form a gene family with a shared ("β3GT") motif (Fig. 1C) . The accession numbers of these β3GT genes and their products are shown in Table I . In addition, a previous review has explained the gene cloning and detailed substrate specificity of these enzymes (22) . Regarding the cloning of β3GnT enzymes involved in polylactosamine synthesis, iGnT (β3GnT1) was the first β3GnT to be isolated (19) . Thereafter, a set of β3GnT genes, polylactosamine structure, which consists of N-acetyllactosamine (Galβ1-4GlcNAc: LacNAc) repeats. The linear polylactosamine structure is also known as a blood group antigen, i antigen. The β1-6-branching polylactosamine structure is also known as a blood group antigen, I antigen. (B) The amino acid sequences in the β3GT subfamily contain well-conserved "β3GT" motifs. Glycosyltransferase genes of the β3GT family contain three conserved β3GT motifs in their amino acid sequence. In the β3GT motif, the DXD sequence that is essential for divalent cation binding is underlined. having sequences similar to those of β3GalTs, has been isolated effectively using in silico bioinformatics analysis (20, 21) . Recently, it was reported that β3GnT1 is involved in the synthesis of glycan on α-dystroglycan, and affects tumor progression (23) . Regarding enzymatic activity toward oligosaccharide substrates, β3GnT2 had clearly stronger activity in vitro on oligosaccharide substrates with polylactosamine structures, suggesting that it is the main polylactosamine synthase (21, 24) . Yeh et al. reported that β3GnT3 is an enzyme that further elongates the core 1 O-glycan structure (25) . β3GnT4 has weak polylactosamine synthetase activity. However, much of the β3GnT4 substrate specificity is unclear.
Lactotriaosylceramide (Lc 3 Cer) is a precursor structure for lacto/neolacto-series glycolipid and polylactosamine chains elongated on Lc 3 Cer. β3GnT5 has been isolated as Lc 3 Cer synthase (24, 26) . Expression of the HNK-1 and Le x antigens on the lacto/neolacto-series of glycolipids has been shown to be developmentally and tissue-specifically regulated by β3GnT5 (synthesizing the lacto/neolacto-series of glycolipids), and this enzyme appears to be closely involved in important functions such as intercellular recognition for the extension of neurons and others (24, (27) (28) (29) . It has been reported that the β3GnT6 is an enzyme that synthesizes the core 3 O-glycan structure (30) . We speculate that this enzyme plays an important role in the synthesis and function of mucin O-glycan in the digestive organs.
Gene expression of β3GnT7 has been reported to be downregulated upon malignant transformation (31) , and is known (to some groups) to synthesize the polylactosamine structure in the cell. Seko et al. have recently shown that β3GnT7 exhibits activity for transferring GlcNAc to Galβ1→4(SO 3 -→6)GlcNAcβ1→3Galβ1→4(SO 3 -→6) GlcNAc (L2L2 oligosaccharide) of keratan sulfate (32) . β3GnT8 transfers GlcNAc to the non-reducing terminus of the Galβ1-4GlcNAc of tetraantennary N-glycan (33) . Furthermore, it has been reported that β3GnT8 and β3GnT2 can form a hetrocomplex with enhanced enzymatic activity (34) . It has been suggested that β3GnT2 and β3GnT8 are cooperatively involved in elongation of polylactosamine chains on multiantennary N-glycans. The structure of the carbohydrate chain synthesized by each β3GnT is shown in Fig. 1D .
Thus, at present, various functional analyses using these cloned genes have been performed, as mentioned below, since the cloning of many genes has been successful. However, it has been unclear how these multiple β3GnTs differentially function in vivo. 
C. Functional Analysis of Glycans Using Glycogene (Glycosyltransferase gene)-Deficient Mice
At mentioned above, more than 186 kinds of glycosyltransferase gene have been cloned. Together with the identification of glycogenes, human diseases caused by abnormalities of glycogenes have become clear. For example, it has been clarified that many diseases such as Congenital Disorders of Glycosylation (CDG) and congenital muscle dystrophy (Muscle-Eye-Brain Disease and Walker-Warburg Syndrome) are caused by abnormalities of glycosyltransferase genes (35) (36) (37) (38) (39) .
It is thought that glycan has an important role in biological functions. In the past, functional analysis of glycan was very difficult. By cloning and analyzing glycogenes, however, now we can generate glycogene-deficient mice and investigate the physiological function of a glycan, glycoprotein, and/or glycolipid in cell.
It is thought that polylactosamine is an important structure with various functions. It is still unclear what molecules carry the polylactosamine chain. In addition, the length of polylactosamine chains on various glycans is not known in detail.
Thus, some research groups have attempted to investigate the functions of polylactosamine by analyzing knockout mice lacking this molecule. For example, it has been reported that one knockout (B3gnt2 -/-) mouse strain lacking polylactosamine exhibits severely disorganized olfactory bulb innervation and defective glomerular formation, resulting in a functional sensory deficit. This suggests that polylactosaimine is required for synapse formation in olfactory bulb innervation (40) .
In order to clarify the role and biological functions of polylactosamine chains on immunologically relevant sites, we have generated and analyzed two strains of B3gnt genedeficient mouse (41, 42) , as outlined below. 
) Mouse
First, we generated and analyzed B3gnt2-deficient (B3gnt2 -/-) mice lacking β3GnT2, which is the major polylactosamine synthase (42) . The number of (long) polylactosamine structures was markedly lower in B3gnt2 -/-mice than in WT mice. To detect polylactosamine structures in this study, we used a lectin, Lycopersicon esculentum (tomato) agglutinin (LEL), which is known to bind to polylactosamines with at least three repeated lactosamine units, as a probe (43, 44) . Flow cytometry using LEL, LEL-blotting analysis and glycan analysis by metabolic labeling demonstrated that the amount of long polylactosamine chains on N-glycans was greatly reduced in the tissues of B3gnt2 -/-mice (42) . This 
suggested that β3GnT2 has major polylactosamine synthase activity for synthesizing polylactosamine chains on N-glycan. Next, we predicted that the B3gnt2 -/-cells would lack polylactosamine chains on N-glycans on their cell-surface glycoproteins. We tried to identify cell-surface proteins carrying polylactosamine by using an antibody-overlay lectin microarray analysis (45) (Fig. 2) . We screened molecules such as major CD antigens (CD4, CD8α, CD19, CD28, and others) from WT lymphocytes and B3gnt2 -/-lymphocytes by lectin microarray analysis. In the case of a polylactosamine-carrier molecule, the immunoprecipitated protein exhibits binding (positive) signals on LEL, STL (Solanum Tuberosum, Potato Lectin), and/or others. We screened polylactosamine-carrier molecules by index for a decrease or loss of lectin signals on target molecules derived from the B3gnt2 -/-mouse. As a result, the LEL signal was decreased on immunoprecipitated CD28 in B3gnt2 -/-T cells as compared with WT T cells (Fig. 3) . Similarly, the LEL signal was decreased on immunoprecipitated CD19 in B3gnt2 -/-B cells (Fig. 4) . We confirmed the loss of polylactosamine chains on these molecules by an alteration in molecular size using Western blot analysis (Fig. 3A, 4A) . 
B3gnt2
-/-T cells proliferated more strongly than WT T cells. On the other hand, B3gnt2 -/-B cells also exhibited upregulation of phosphorylation signals on stimulation with anti-BCR antibody (Fig. 4B) . B3gnt2 -/-B cells also showed hyperproliferation on BCR stimulation (Fig. 4C) . These studies show that lack of polylactosamine chains on N-glycans results in enhanced initiation of immune responses by T cells and B cells.
E. Analysis of Immunological Disorder (Phenotype) in the
B3gnt5-Deficient (B3gnt5 -/-) Mouse S e c o n d , w e g e n e r a t e d a n d a n a l y z e d B 3 g n t 5 -deficient (B3gnt5 -/-) mice lacking β3GnT5, which is a lactotriaosylceramide (Lc 3 Cer) synthase synthesizing polylactosamine chains on glycolipids (41) . B3gnt5 -/-mice showed loss of the precursor structure for lacto/neolactoseries glycolipids (containing polylactosamine chains). We analyzed the glycan structure of glycolipids derived from WT and B3gnt5 -/-mice. On biochemical analyses, lacto/neolactoseries glycolipids were confirmed to be absent and no Lc 3 Cer synthase activity was detected in the tissues of B3gnt5 -/-mice. In addition, mass spectrometric analysis revealed that lacto and neolacto-glycolipids had disappeared in B3gnt5 -/-B cells. These results demonstrate that β3GnT5 is the sole enzyme synthesizing Lc 3 Cer in vivo.
Next, we performed functional analysis (phenotype screening) using immune cells, especially B cells. We screened for phenotypes related to glycolipid-enriched microdomains (GEMs, also known as glycolipid rafts, or detergent-resistant membrane structures, DRMs) (46) (47) (48) (49) , because the product of β3GnT5 is Lc 3 Cer glycolipid and this glycolipid exists in microstructures such as GEMs on the cell surface. GEMs are composed of cholesterol, sphingolipid, glycolipid, and others. In general, GEMs are essential cellular structures for localizing signal transduction (50, 51) , and lacto/ neolacto-series glycolipids containing polylactosamine are thought to be localized in GEMs. Thus, we thought that these glycolipids might have a function in GEMs.
One glycolipids, GM1 ganglioside, is used as a GEM marker. Thus, we analyzed GEM structure in B cells by GM1 staining with fluorescently labeled cholera toxin B subunit.
GM1 staining was significantly upregulated in B3gnt5
-/-B cells as compared with WT B cells by fluorescence microscopy analysis (Fig. 5A) . The GEM-stained puncta on the surface of B3gnt5 -/-resting B cells were brighter and larger than those of WT cells. These results suggest that structural alteration of GEMs occurs in B3gnt5 -/-B cells. At present, however, the detailed phenomenon and molecular mechanism are unknown.
The major biological function of B cells is immune response and signal transduction involving the BCR and BCR-related molecules. Many studies reported that the BCR and BCR-related molecules such as CD19 transmit their signals in GEMs on the cell surface. In the case of B cells, BCR and CD19 proteins are found outside of GEMs without stimulation. However, these molecules flow to the inside of GEMs after antigen stimulation. This leads to an accumulation of BCR, CD19 and signal transduction molecules in the GEMs. The intracellular signal is then delivered to each cell.
We therefore examined whether BCR signaling-related proteins, such as the BCR, CD19 and the signaling molecule Lyn, had moved into or out of the GEM fraction. These molecules were enriched in the GEM fraction of B3gnt5 -/-B cells (Fig. 5B) . Moreover, B3gnt5
-/-B cells were more sensitive to the induction of intracellular phosphorylation signals on BCR stimulation (Fig. 6A) , and B3gnt5 -/-B cells proliferated more vigorously than WT B cells (Fig. 6B) . Moreover, T cellindependent antibody production was slightly upregulated at an early stage of the response in B3gnt5 -/-mice as compared -/-B cells, with or without stimulation, was performed using one-way ANOVA and Tukey testing by GraphPad PRISM4 software. Data are given as each cell and means (bold line) and standard deviation. P values are *1: P<0.01, *2: P<0.01. (B) Distribution of BCR, CD19, and Lyn in GEMs separated into fractions by sucrose density gradient centrifugation. B cells stimulated with anti-BCR and anti-CD19 antibodies were lysed with 1% Triton X-100 solubilization buffer. After sucrose gradient centrifugation, fractions were collected from the top of the gradient. Next, every second fraction was combined starting from the top fraction. GM1, as a GEM marker, was detected using HRP-conjugated CT-B, as shown in the upper panel. After fractionation, immunoprecipitation of the BCR and CD19 was performed using anti-BCR and anti-CD19 antibody, respectively. BCR (sIgM) and CD19 proteins in B3gnt5 -/-B cells were upregulated in the GEM fraction (fractions 1-4). Lyn protein was also upregulated in the GEM fraction of B3gnt5 -/-B cells. The results shown are representative of several independent experiments. *: non-specific bands.
with WT mice (Fig. 6C) . These results suggested that B3gnt5 -/-B cells tend to be more easily activated by BCR stimulation as compared with WT B cells.
Together, these results suggest that lacto/neolactoseries glycolipids containing polylactosamine play an important role in controlling the clustering and stabilization of GEMs as a platform for signal transduction, and thereby regulate the movement of specific proteins, such as BCRrelated molecules, to GEMs.
In addition, some research groups have generated and analyzed different strains of B3gnt5-deficient mice (41, (52) (53) (54) . It has been reported that disruption of the B3gnt5 gene leads to abnormalities in reproduction function such as preimplantation lethality, sex behavior, and immune response (52) (53) (54) . There are many differences among the B3gnt5-deficient mouse strains. At present, however, it is unclear why these differences were observed. 
F. Regulation of the Immune Response by Polylactosamine
Our work has strongly indicated that the long polylactosamine chains on N-glycans are synthesized by β3GnT2 (42) . In addition, lacto and neolacto-series glycolipids are synthesized by β3GnT5 (41) . These studies suggested that polylactosamine deficiency either on receptor glycoproteins on the cell surface or on glycolipids leads to hyperresponsiveness of lymphocytes to external stimuli.
Our studies also suggested that polylactosamine chains on glycoproteins (N-glycans) play important roles in controlling the assembly and stabilization of receptor complexes via an inhibitory mass effect of polylactosamine on molecular interactions. In addition, our study suggested that lacto/neolacto-series glycolipids play an important role in the formation and function of GEM structures. From these studies, we think that the polylactosamine chain is one of the important factors that determines the thresholds for immune responses at a cellular level.
On the cell surface, there seems to be a microstructure known as a lattice structure ((poly)lactosamine-mediated lattice) (55, 56) (Fig. 7A , left side of figure, lattice theory). This lattice structure is formed by cross-linking between glycoproteins (containing multivalent glycan) and endogenous lectins (having multivalent binding sites), such as galectin (57) . The lattice structures regulate signal transduction and the threshold of cellular responses by controlling movement and turnover (half-life) of receptor glycoproteins (58) (59) (60) (61) . In addition, it is thought that lattice structures modulate cellular interactions.
In WT mice, BCR proteins are associated after stimulation and form a GEM structure. This response occurs forcibly under the limitation of molecular actions by the lattice structure. This response results in intracellular signaling to each cell and activation of cells.
In our study on the B3gnt2 -/-mouse, we found -/-mice, lack of polylactosamine on glycoproteins induces disappearance of the lattice structure. This makes it easier for receptor glycoproteins to move around on the cell surface. We think that hypoglycosylation of glycoprotein receptors may regulate binding affinity between the receptor and its ligand, or it may regulate association of receptor. In general, GEMs (lipid rafts) are known to be essential for the localization of signal transduction. An important issue in GEM function is aggregation. Under the naïve condition before stimulation, it is known that GEMs are small structures. By clustering GEM-associated proteins, the small individual GEMs cluster into larger, visible and functional units. GEM formation is reversible, and GEMs exist only as transiently stabilized structures. In B3gnt5 -/-B cells, larger GEM units are made more rapidly as compared with WT B cells. B3gnt5 -/-B cells showed a marked increase in BCR-related molecules, such as BCR, CD19, and the signaling molecule Lyn, in GEMs as compared with WT mice. There are at least two possible molecular mechanisms that could be responsible for the phenomenon observed in B3gnt5 -/-B cells. First, BCR/CD19 complexes might be transferred efficiently into GEMs, because many more clustered GEMs are formed in B3gnt5 -/-B cells than in WT B cells. Second, polylactosamine on glycolipids might control the behavior of glycoprotein entry into or exclusion from GEMs. Dissecting the detailed mechanisms responsible for enhanced GEM formation in B3gnt5 -/-B cells is an attractive subject for future study. In summary, these observations suggest that polylactosamine-deficient cells lead to upregulation of immune responses by abnormal movement of cell-surface proteins and/or formation of the GEM microstructure.
polylactosamine on the immune co-stimulatory molecules CD28 and CD19, and showed that polylactosamine levels on these molecules were reduced in B3gnt2 -/-immunocytes. In B3gnt2 -/-mice, a reduction of polylactosamine on glycoproteins leads to a lack of lattice structure. We assume that this makes it easier for receptor proteins such as CD28 or CD19, to move around on the cell surface. Consequently, the clustering of receptor proteins in B3gnt2 -/-mice occurs at an earlier stage than in the WT mouse (Fig. 7, right of figure) . These observations suggest that B3gnt2 -/-lymphocytes tend to be more easily activated by stimulation as compared with WT lymphocytes. We think that hypoglycosylation of glycoprotein receptors may regulate binding affinity between the receptor and its ligand, or it may regulate association of the receptor.
It has been reported that glycolipid are not essential for formation of GEMs (62). However, from our studies on the B3gnt5 -/-mouse, we think that polylactosamine on glycolip ids may play an important role in forming the GEM structure as a signaling platform on the cell surface. Both the association of receptor complexes and the platform formed by clustered GEMs are important for signaling via GEMs. In B3gnt5 -/-resting B cells, the small GEMs can easily aggregate into larger units when receptor complexes are formed. Some relations between GEMs and the lattice structure may exist, because it is known that some galectins are localized in the GEM structure. At present, the details of the molecular mechanism are still unclear, but the GEM structure is thought to be stable in B3gnt5 -/-B cells. In any case, larger GEM units are made more rapidly in B3gnt5 -/-B cells as compared with WT B cells. Therefore, a larger amount of BCR-related proteins such as the BCR and CD19 molecule, flow into GEMs and activate cells (Fig. 7B ). These observations suggest that B3gnt5 -/-B cells tend to be more easily activated after stimulation as compared with WT lymphocytes.
Taken together, these studies have demonstrated that polylactosamine deficiency on glycolipids causes various abnormalities in cellular function through regulation of receptor function and GEM formation. However, further work is needed to clarify both the mechanism of these phenotypes and the hypothesis in detail.
G. Future Perspective
As a first step to further clarify the function and importance of specific carbohydrate structure, glycogenedeficient mice have been generated and investigated.
I n o r d e r t o e l u c i d a t e t h e d e t a i l e d r o l e o f polylactosamine chains on biologically relevant sites, initially we cloned glycosyltransferase genes belonging to the β1,3-glycosyltransferase family, especially β3GnTs. Subsequently, many studies have shown that these enzymes have different substrate specificities, synthesize characteristic carbohydrate We raise the possibility that the polylactosamine structure on glycoproteins and/or glycolipids might have significant effects on biological function in the immune system. We believe that gene cloning and analysis of glycogene-deficient mice has laid the basis for further clarification of the importance of functional carbohydrate structures such as polylactosamine.
